Thursday, October 11, 2012
The Leukemia & Lymphoma Society has
announced its first research partnership with a large biopharma company-a
four-year, multimillion-dollar deal with Celgene Corp. to solicit and fund
proposals from academics and smaller biotechs. The not-for-profit organization
expects the deal's framework to serve as a template for future collaborations
and is in talks with additional big biotech and pharma companies.
Cain, C. SciBX 5(40); doi:10.1038/scibx.2012.1046
Published online Oct. 11, 2012
AND INSTITUTIONS MENTIONED
Celgene Corp. (NASDAQ:CELG), Summit, N.J.
Leukemia & Lymphoma Society, White Plains, N.Y.